本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Stoke Therapeutics, Inc.

9.36
+0.31003.43%
盤後9.360.00000.00%19:38 EDT
成交量:119.73萬
成交額:1,121.61萬
市值:5.11億
市盈率:-5.68
高:9.60
開:9.07
低:9.05
收:9.05
資料載入中...
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/18

SEC問詢函

Form CORRESP - Correspondence
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

重要事件披露

Form 8-K - Current report
2023/09/21

重要事件披露

Form 8-K - Current report